Newly proposed therapy-related myelodysplastic syndrome prognostic score predicts significant differences in overall survival and leukemia-free survival in patients treated with azacitidine

Massimo Breccia; Luana Fianchi; Monia Lunghi; G Gaidano; A Levis; C Finelli; V Santini; P Musto; G Mansueto; En Oliva; P Leoni; Maa Spiriti; Stefan Hohaus; Giuseppe Leone; G Alimena; Maria Teresa Voso

doi:10.3109/10428194.2012.749406

Newly proposed therapy-related myelodysplastic syndrome prognostic score predicts significant differences in overall survival and leukemia-free survival in patients treated with azacitidine

Massimo Breccia, Luana Fianchi, Monia Lunghi, G Gaidano, A Levis, C Finelli, V Santini, P Musto, G Mansueto, En Oliva, P Leoni, Maa Spiriti, Stefan Hohaus, Giuseppe Leone, G Alimena, Maria Teresa Voso

Risultato della ricerca: Contributo in rivista › Articolo in rivista › peer review

Abstract

NO ABSTRACT

Lingua originale	English
pagine (da-a)	N/A-N/A
Rivista	LEUKEMIA & LYMPHOMA
Volume	2013
DOI	https://doi.org/10.3109/10428194.2012.749406
Stato di pubblicazione	Pubblicato - 2012

Keywords

MYELODYSPLASTIC SYNDROME

Accesso al documento

10.3109/10428194.2012.749406

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

Breccia, M., Fianchi, L., Lunghi, M., Gaidano, G., Levis, A., Finelli, C., Santini, V., Musto, P., Mansueto, G., Oliva, E., Leoni, P., Spiriti, M., Hohaus, S., Leone, G., Alimena, G., & Voso, M. T. (2012). Newly proposed therapy-related myelodysplastic syndrome prognostic score predicts significant differences in overall survival and leukemia-free survival in patients treated with azacitidine. LEUKEMIA & LYMPHOMA, 2013, N/A-N/A. https://doi.org/10.3109/10428194.2012.749406

@article{1aaf90ecb96748858552709779fba452,

title = "Newly proposed therapy-related myelodysplastic syndrome prognostic score predicts significant differences in overall survival and leukemia-free survival in patients treated with azacitidine",

abstract = "NO ABSTRACT",

keywords = "MYELODYSPLASTIC SYNDROME, MYELODYSPLASTIC SYNDROME",

author = "Massimo Breccia and Luana Fianchi and Monia Lunghi and G Gaidano and A Levis and C Finelli and V Santini and P Musto and G Mansueto and En Oliva and P Leoni and Maa Spiriti and Stefan Hohaus and Giuseppe Leone and G Alimena and Voso, {Maria Teresa}",

year = "2012",

doi = "10.3109/10428194.2012.749406",

language = "English",

volume = "2013",

pages = "N/A--N/A",

journal = "LEUKEMIA & LYMPHOMA",

issn = "1042-8194",

publisher = "Taylor & Francis Limited:Rankine Road, Basingstoke RG24 8PR United Kingdom:011 44 1256 813035, EMAIL: [email protected], [email protected], INTERNET: http://www.tandf.co.uk, Fax: 011 44 1256 330245",

}

Breccia, M, Fianchi, L, Lunghi, M, Gaidano, G, Levis, A, Finelli, C, Santini, V, Musto, P, Mansueto, G, Oliva, E, Leoni, P, Spiriti, M, Hohaus, S, Leone, G, Alimena, G & Voso, MT 2012, 'Newly proposed therapy-related myelodysplastic syndrome prognostic score predicts significant differences in overall survival and leukemia-free survival in patients treated with azacitidine', LEUKEMIA & LYMPHOMA, vol. 2013, pagg. N/A-N/A. https://doi.org/10.3109/10428194.2012.749406

Newly proposed therapy-related myelodysplastic syndrome prognostic score predicts significant differences in overall survival and leukemia-free survival in patients treated with azacitidine. / Breccia, Massimo; Fianchi, Luana; Lunghi, Monia et al.
In: LEUKEMIA & LYMPHOMA, Vol. 2013, 2012, pag. N/A-N/A.

Risultato della ricerca: Contributo in rivista › Articolo in rivista › peer review

TY - JOUR

T1 - Newly proposed therapy-related myelodysplastic syndrome prognostic score predicts significant differences in overall survival and leukemia-free survival in patients treated with azacitidine

AU - Breccia, Massimo

AU - Fianchi, Luana

AU - Lunghi, Monia

AU - Gaidano, G

AU - Levis, A

AU - Finelli, C

AU - Santini, V

AU - Musto, P

AU - Mansueto, G

AU - Oliva, En

AU - Leoni, P

AU - Spiriti, Maa

AU - Hohaus, Stefan

AU - Leone, Giuseppe

AU - Alimena, G

AU - Voso, Maria Teresa

PY - 2012

Y1 - 2012

N2 - NO ABSTRACT

AB - NO ABSTRACT

KW - MYELODYSPLASTIC SYNDROME

UR - http://hdl.handle.net/10807/39895

U2 - 10.3109/10428194.2012.749406

DO - 10.3109/10428194.2012.749406

M3 - Article

SN - 1042-8194

VL - 2013

SP - N/A-N/A

JO - LEUKEMIA & LYMPHOMA

JF - LEUKEMIA & LYMPHOMA

ER -

Newly proposed therapy-related myelodysplastic syndrome prognostic score predicts significant differences in overall survival and leukemia-free survival in patients treated with azacitidine

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo